You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Details for Patent: 10,548,943


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,548,943 protect, and when does it expire?

Patent 10,548,943 protects GIAPREZA and is included in one NDA.

Summary for Patent: 10,548,943
Title:Method of treating low blood pressure
Abstract: A method for treating a patient suffering from one of septic shock, acute kidney injury, severe hypotension, cardiac arrest, and refractory hypotension, but not from myocardial infarction, is provided. The method includes administering a therapeutically effective dose of Angiotensin II, or Ang II, to the patient.
Inventor(s): Chawla; Lakhmir S. (McLean, VA)
Assignee: The George Washington University a Congressionally Chartered Not-for-Profit Corporation (Washington, DC)
Application Number:16/439,881
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,548,943: A Comprehensive Guide

Introduction to Patent Analysis

When analyzing a patent, it is crucial to understand the scope, claims, and the broader patent landscape. This article will delve into the details of United States Patent 10,548,943, providing a comprehensive analysis of its scope, claims, and the context within which it exists.

Understanding the Patent System

Before diving into the specifics of the patent, it's essential to understand the patent system. The U.S. Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and registering trademarks. The process involves a thorough search of prior art to ensure the novelty and non-obviousness of the invention[2].

Tools for Patent Search

Several tools are available for conducting a patent search, including the Patent Public Search tool, Global Dossier, Public Search Facility, and Patent and Trademark Resource Centers (PTRCs). These resources help in identifying existing patents and published patent applications, which is critical for determining the novelty of an invention[1].

Patent 10,548,943 Overview

To analyze the scope and claims of United States Patent 10,548,943, one must first identify the patent's title, abstract, and detailed description. Here is a general outline of what this involves:

Title and Abstract

The title and abstract provide a brief overview of the invention. This is where you can get a preliminary understanding of what the patent covers.

Detailed Description

The detailed description section elaborates on the invention, including its components, methods, and any specific embodiments.

Scope of the Patent

Claims

The claims section is the most critical part of a patent as it defines the scope of the invention. Claims are the legal boundaries of what is protected by the patent. There are two types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. This is often a point of contention in patent litigation, as the interpretation can significantly impact the patent's validity and enforceability.

Analyzing the Claims of Patent 10,548,943

Independent Claims

Independent claims in Patent 10,548,943 would outline the core aspects of the invention. For example, if the patent is for a medical device, the independent claims might describe the device's structure, its primary function, and any unique features.

Dependent Claims

Dependent claims would further specify the invention by adding additional limitations. These claims are narrower and build upon the independent claims.

Claim Examples

For instance, if the patent is for a therapeutic method, an independent claim might state:

  • "A method for treating hypotension, comprising administering a composition containing angiotensin II, angiotensin III, or angiotensin IV." A dependent claim could then specify:
  • "The method of claim 1, wherein the composition is administered intravenously."

Patent Landscape Analysis

Prior Art Search

To understand the patent landscape, a thorough prior art search is necessary. This involves using tools like the Patent Public Search, Global Dossier, and international patent databases to identify related patents and applications[1].

Competitor Patents

Identifying competitor patents helps in understanding the existing technology and how the patent in question differentiates itself. This can involve analyzing patents from other companies or inventors in the same field.

International Patent Filings

Checking for international patent filings through databases like the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) can provide a global perspective on the patent's scope and potential conflicts[1].

Legal and Regulatory Considerations

Patent Infringement

Understanding the claims and scope of the patent is crucial for determining potential infringement. Companies must ensure that their products or methods do not infringe on the claims of Patent 10,548,943.

Litigation and Defense

In cases of patent disputes, the scope and claims of the patent become central to litigation. Companies like La Jolla Pharmaceutical Company vigorously defend their intellectual property rights, often relying on the Hatch-Waxman Act for protection against generic competitors[4].

Economic and Strategic Implications

Market Impact

The scope and claims of a patent can significantly impact the market. A broad scope can provide a competitive advantage by preventing others from entering the market with similar products or methods.

Licensing and Collaboration

The patent's scope can also influence licensing agreements and collaborations. Companies may seek to license the technology or collaborate with the patent holder to avoid infringement and leverage the patented invention.

Data and Statistics

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications. This dataset can be used to analyze trends in patent scope and claims, offering insights into how patents like 10,548,943 fit into the broader patent landscape[3].

Conclusion

Analyzing the scope and claims of United States Patent 10,548,943 involves a detailed examination of the patent's claims, a thorough prior art search, and an understanding of the broader patent landscape. This analysis is crucial for determining the patent's validity, potential infringement, and strategic implications.

Key Takeaways

  • Claims Define Scope: The claims section of a patent defines its legal boundaries.
  • Prior Art Search: A thorough search of prior art is essential for understanding the patent's novelty and non-obviousness.
  • International Filings: Checking international patent filings provides a global perspective on the patent's scope.
  • Legal and Regulatory Considerations: Understanding the patent's scope is crucial for litigation and defense against infringement.
  • Economic Implications: The patent's scope can significantly impact market competition and licensing agreements.

FAQs

What is the purpose of the claims section in a patent?

The claims section defines the legal boundaries of what is protected by the patent, outlining the specific aspects of the invention.

How do I conduct a prior art search for a patent?

You can conduct a prior art search using tools like the Patent Public Search, Global Dossier, and international patent databases such as the EPO and WIPO[1].

What is the significance of international patent filings?

International patent filings help in understanding the global scope of the patent and potential conflicts with other patents filed in different countries.

How can a company defend its patent against infringement?

A company can defend its patent by vigorously enforcing its intellectual property rights, often relying on laws like the Hatch-Waxman Act, and engaging in litigation if necessary[4].

What is the Patent Claims Research Dataset?

The Patent Claims Research Dataset is a collection of data provided by the USPTO that contains detailed information on claims from U.S. patents and applications, useful for analyzing trends in patent scope and claims[3].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Marketscreener - LA JOLLA PHARMACEUTICAL CO: https://www.marketscreener.com/quote/stock/LA-JOLLA-PHARMACEUTICAL-C-23894309/news/LA-JOLLA-PHARMACEUTICAL-CO-Other-Events-Financial-Statements-and-Exhibits-form-8-K-39490691/

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,548,943

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-003 Dec 23, 2021 RX Yes Yes 10,548,943 ⤷  Try for Free INCREASING BLOOD PRESSURE WITH A RATE OF ABOUT 20 NG/KG/MIN TO ABOUT 40 NG/KG/MIN ANGIOTENSIN II IN A HUMAN SUBJECT HAVING SEPTIC SHOCK ⤷  Try for Free
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-003 Dec 23, 2021 RX Yes Yes 10,548,943 ⤷  Try for Free INCREASING BLOOD PRESSURE WITH AN INITIAL RATE OF ABOUT 20 NG/KG/MIN ANGIOTENSIN II IN A HUMAN SUBJECT HAVING SEPTIC SHOCK, AND TITRATING THE RATE UP. ⤷  Try for Free
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-001 Dec 21, 2017 RX Yes Yes 10,548,943 ⤷  Try for Free INCREASING BLOOD PRESSURE WITH A RATE OF ABOUT 20 NG/KG/MIN TO ABOUT 40 NG/KG/MIN ANGIOTENSIN II IN A HUMAN SUBJECT HAVING SEPTIC SHOCK ⤷  Try for Free
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-001 Dec 21, 2017 RX Yes Yes 10,548,943 ⤷  Try for Free INCREASING BLOOD PRESSURE WITH AN INITIAL RATE OF ABOUT 20 NG/KG/MIN ANGIOTENSIN II IN A HUMAN SUBJECT HAVING SEPTIC SHOCK, AND TITRATING THE RATE UP. ⤷  Try for Free
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-002 Dec 21, 2017 DISCN Yes No 10,548,943 ⤷  Try for Free INCREASING BLOOD PRESSURE WITH A RATE OF ABOUT 20 NG/KG/MIN TO ABOUT 40 NG/KG/MIN ANGIOTENSIN II IN A HUMAN SUBJECT HAVING SEPTIC SHOCK ⤷  Try for Free
La Jolla Pharma GIAPREZA angiotensin ii acetate SOLUTION;INTRAVENOUS 209360-002 Dec 21, 2017 DISCN Yes No 10,548,943 ⤷  Try for Free INCREASING BLOOD PRESSURE WITH AN INITIAL RATE OF ABOUT 20 NG/KG/MIN ANGIOTENSIN II IN A HUMAN SUBJECT HAVING SEPTIC SHOCK, AND TITRATING THE RATE UP. ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.